WHAT'S KNOWN ON THIS SUBJECT: As more children with sickle cell disease survive into adulthood, they are increasingly hospitalized in both children' s and general hospitals and managed by different provider specialists. But it is unknown if hospital type and provider specialty affect patient outcomes.
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Acute chest syndrome (ACS) is the leading cause of death in patients with sickle cell disease (SCD) and, after vasoocclusive pain, the most common reason for hospitalization. [1] [2] [3] The incidence of ACS peaks at 2-to 4-years of age, but an ACS episode has been found to be 4 times more likely to be fatal in an adult than in a child. A prospective study of over 3751 patients with SCD enrolled from birth to age 66 years revealed that 939 (25.0%) patients had at least 1 episode of ACS and that disease severity increased dramatically with age. 4 The diagnosis of ACS requires radiographic evidence of a new pulmonary infiltrate along with chest pain, fever, respiratory symptoms, and/or hypoxemia. In half of hospitalized patients with ACS, these manifestations are either missed or absent on admission. 1 In response to evidence that rapid intervention may halt the progression of ACS, 1 some institutions have implemented clinical guidelines for the diagnosis, treatment, and monitoring of ACS. These guidelines typically call for fluid resuscitation, pain control, antibiotics, bronchodilators, transfusion, and aggressive respiratory support. 5, 6 Historically, SCD-associated ACS was considered a disease of early childhood. However, comprehensive care for infants and children with SCD has doubled survival to adulthood and increased the numbers of adolescents and young adults (A/YA) with SCDrelated complications such as ACS. A prospective study of nearly 1000 individuals with SCD diagnosed at birth and followed-up to 27 years revealed that overall SCD-related mortality rate was 3 times higher in those aged 15 to 27 years of age compared with those aged 14 years and younger. 7 ACS remained the leading cause of death, raising concerns that diagnosis and/or intervention may be delayed as patients with SCD transition from pediatric-to adult-care providers.
Our objective was to explore the effects of hospital type and provider specialty on the management and outcome of ACS in adolescent and young adult patients with SCD. Our primary hypothesis was that patients aged 16 to 25 years with SCD-associated ACS who are cared for in children' s hospitals and/or by hematology-trained providers are less likely to progress to endotracheal intubation or death than those cared for in general hospital and/or by nonhematologists. We also hypothesized that patients cared for in children' s hospitals and/or by hematologytrained providers were more likely to undergo simple or exchange transfusion, have longer lengths of stay, 8 and have lower 30-day readmission rates compared with those cared for in general hospitals and/or by nonhematologists.
METHODS

Data Source and Study Population
We used the Perspective Data Warehouse (PDW), maintained by Premier Inc (Charlotte, NC), as our primary data source. PDW is the largest clinical and operational data warehouse in the nation and contains longitudinal inpatient and ambulatory data from over 600 hospitals representing a broad array of academic medical centers, communitybased hospitals, and large systems of multiple hospitals distributed throughout the United States. 9 PDW was previously found to be sufficiently similar to a probability-based sample of pediatric hospitalizations, specifically the Agency for Healthcare Research and Quality Kids' Inpatient Database. 10 14 Lengths of stay and 30-day readmission were calculated directly from the data set.
Exposures
Hospital type was coded as a dichotomous variable, children' s hospital or general hospital. A hospital was designated a children's hospital by PDW if the hospital held membership in the National Association of Children' s Hospitals and Related Institutions or was defined as a children' s hospital by the American Hospital Association. All other hospitals were designated general hospitals. The distribution of patient ages and hospital characteristics among children' s hospitals and general hospitals within PDW was comparable to the characteristics among children' s hospitals and other hospitals within the national Kids' Inpatient Database.
Provider specialty for each hospital admission was coded as a categorical variable, generalist, hematologist, or other. Generalist was defined as general pediatrics, general internal medicine, family medicine, or hospitalist. Hematologist was defined as pediatric hematology-oncology or adult hematology. All other provider specialties were designated as other.
Covariates
Hospital-level variables included size (small, ,250 beds; medium, 250-499 beds; large, $500 beds); region of the country, categorized as North, South, Midwest, and West; teaching status; location in an urban or rural area; and SCD volume (annual admissions of patients aged 16-25 years with SCD). Patient-level variables included age; gender; race, categorized as black or nonblack; and insurance payer, categorized as private or nonprivate. Two standardized case-mix measures derived from the APR-DRG were included in the analyses. The APR-DRG Severity of Illness measure and the APR-DRG Risk of Mortality measure were developed for use in nonelderly populations by the Healthcare Cost & Utilization Project of the Agency for Healthcare Research and Quality. Each measure assigns the patient to a subclass, ranging from 1 to 4 for use in nonelderly populations. 15 For disease severity adjustment, we included the following variables available from the claims data: number of complex chronic conditions beyond SCD [16] [17] [18] ; number of hospital admissions and ICU admissions in the 90 days before the index admission; admission type, categorized as elective and nonelective; transfer from another hospital; hydroxyurea use on hospital day 0 to 1; and resource utilization on admission. Hydroxyurea use on day 0 to 1 of the index hospitalization was used as a proxy for outpatient hydroxyurea use before hospitalization. Long-term use of hydroxyurea in adults has been shown to decrease ACS frequency and mortality. 11, [19] [20] [21] [22] Resource utilization on admission was used as a measure of illness severity on admission and was calculated by totaling hospital charges on hospital day 0 and 1 for each patient. To account for variation in resource utilization across different individual hospitals, total hospital charges on admission was then standardized to those of all patients in the same age group admitted to the same hospital. 23 
Analysis
Admissions in general hospitals and children' s hospitals were compared for each hospital-level variable, patientlevel variable, and outcome variable by using Pearson' s x 2 test for categorical variables, Yates corrected x 2 or Fisher' s exact test for dichotomous variables, and 1-way analysis of variance for continuous variables. Variables known or theorized to affect risk of adverse outcomes for ACS were included in the model a priori. These included age, number of complex chronic conditions, hydroxyurea use on admission, and hospital SCD volume. Because nearly all covariates were associated with hospital type at P , .05, we adjusted for all covariates in the multilevel regression methods exploring the independent associations of hospital type and provider specialty with the outcome measures. When repeated admissions were clustered at the hospital and patient levels, hospital-level design effects on parameter estimation overwhelmed patient-level effects. The final models, therefore, were simplified by accounting only for hospital-level effects. After confirming an interaction effect between hospital type and provider specialty, we then conducted within-group analysis to compare the effect of hospital type on death or intubation within each provider specialty group.
We used multivariate logistic regression models to assess the association of hospital type and provider specialty with the dichotomous outcome measures, death or intubation, use of simple or exchange transfusion, and readmission within 30 days. Zero-truncated negative binomial multivariate regression models were used to assess the association of the exposures with length of stay (LOS). For ease of interpretation, estimates from these logistic or zerotruncated negative binomial models were marginally standardized as predicted probabilities or predicted margins of each outcome across hospital type and provider specialty.
All analyses were performed by using Stata 10.0 (Stata Corp, College Station, TX).
RESULTS
During the 3-year study period, there were 2299 admissions of 1476 patients aged 16 to 25 years with ACS. We excluded 77 admissions (3.4% of all admissions) in which the primary exposure, children' s hospital or general hospital, could not be identified. We also excluded 44 admissions (1. Table 1 ). The mean and median volume of SCD-related admissions for all hospitals was 8.7 and 4 admissions per year. Children' s hospitals averaged 28.6 SCD-related admissions of patients aged 16 to 25 years per year with a median of 16 admissions. In contrast, general hospitals averaged 7.7 SCDrelated admissions per year with a median of 4 admissions. Half the hospitals were located in the US south.
The mean age in the cohort was 21.1 6 2.6 years. Fifty-five percent of the cohort was male and 22% had private insurance. Forty-one percent had a complex chronic condition other than SCD, 33% were hospitalized in the past 90 days, and ,2% required an ICU admission in the past 90 days. Admissions to general hospitals were associated with a complex chronic condition other than SCD and an ICU admission in the last 90 days. There were no significant differences in other disease severity and case-mix measures between admissions to pediatric hospitals versus general hospitals (Table 2) .
If admitted to a general hospital, 75% of the cohort were managed by a generalist provider; in contrast, nearly half (46%) of the cohort in children' s hospitals were managed by a hematologist.
A total of 14 patients admitted with ACS died in our sample (0.6% of all hospitalizations). All patients who died were $18 years; 10 patients were $21 years. Three of 14 were taking hydroxyurea on admission. Nine of 14 had a complex chronic condition beyond SCD. Thirteen of 14 deaths took place in a general hospital. Eleven of 14 deaths were with generalist physicians; 1 of 14 was with a pediatric hematologist; and 2 of 14 were with other specialists (intensivist and pulmonologist).
Nearly half (44.6%) of admissions with ACS underwent endotracheal intubation. The unadjusted probability of intubation was 48% in general hospitals compared with 26% in children' s hospitals (P , .001; Table 3 ). There was no difference in the unadjusted probability of intubation across provider specialties (P = .898). In multivariate adjustment, the main effect of hospital type on intubation remained significant. The predicted probability (PP) of intubation was 48% in general hospitals compared with 24% in children' s hospitals (P = .045).
Also significant was the interaction between hospital type and provider specialty (Table 4) Almost half (46%) of ACS admissions received a simple transfusion (43%), exchange transfusion (2%), or both (1%). The unadjusted probability of transfusion was 49% in general hospitals compared with 29% in children' s hospitals (Table 3 ) but was not significant after multivariate adjustment (P = .067). There were no differences in the unadjusted probability of transfusion among the provider specialties. A strong interaction effect was again seen between hospital type and provider The overall 30-day readmission rate was 8.7%. There were no differences in 30-day readmission rates with respect to differences in hospital type or provider specialty (Table 3) .
DISCUSSION
In this national all-payer study of adolescent and young adult hospitalizations with SCD and ACS, we found higher rates of intubation and longer lengths of stay in general hospitals compared with children' s hospitals. Across all hospitals, there were no significant differences in intubation or transfusion by provider specialty.
The higher intubation risk and longer lengths of stay in general hospitals compared with children' s hospitals may suggest that children' s hospitals have mechanisms and expertise leading to improved outcomes compared with general hospitals. This difference may also suggest that adolescent and young adult patients admitted to general hospitals are sicker at presentation because they are aging out of pediatric care and are having difficulty accessing ongoing adult care. In our study, patients in general hospitals had more complex chronic conditions and previous ICU admissions than those in children' s hospitals.
Most children with SCD in the United States are followed at SCD centers in large academic children' s hospitals. They age out of these centers as A/YA (26), pediatric subspecialties (10), emergency medicine (6), general surgery or surgical subspecialties (6), critical care medicine or anesthesiology (5), psychiatry (3), and physical medicine and rehabilitation (1) . P values based on chi-squared distribution for categorical variables. c Resource utilization was calculated by totaling hospital charges on hospital day 0 and 1 for each patient, which was then standardized to same hospital charges of all patients in the same age group admitted to the same hospital.
when they are at greatest risk for uninsurance or insurance lapses. [24] [25] [26] [27] Most encounter difficulty identifying adult providers comfortable managing SCD. 28, 29 Consequently A/YA have fragmented care at both the provider and hospital level compared with other age groups 30 and may be less adherent or not prescribed proven outpatient therapies, such as hydroxyurea. 10, 12, [18] [19] [20] [21] 28 Although our study is limited by its inability to know which hospitals are SCD centers or to directly observe continuity or quality of outpatient care, we found that patients in general hospitals were less likely to be on hydroxyurea on admission. Although there were few deaths in our sample, other studies have revealed that young adults with SCD experience a sharp increase in age-specific mortality after transition to adult care. 31 We may improve outcomes in general hospitals by minimizing insurance lapses, training more adult providers in SCD care, and developing policies that improve care coordination as A/YA transition to adult care.
SCD-specific hospital volume and access to SCD specialists may also partly explain the variation between children' s and general hospitals. McCavit et al 33 showed that hospitals with low SCD-specific volumes had higher mortality rates than hospitals with high-volumes. High-volume hospitals may have increased access to specialists (such as pediatric hematologists) and other clinical staff who possess specialized training in managing SCD. General hospitals may improve outcomes through regionalization of SCD care, as has been done with systems of care for adults with cystic fibrosis.
Regionalization of care may also improve our capacity to generate, disseminate, and implement best practices of SCD care, especially among older patients with SCD. For example, the efficacy of transfusion in suspected cases of ACS is not definitive and quality measures, such as 30-day readmissions, are controversial. [34] [35] [36] Notably, despite current guidelines recommending transfusion in suspected ACS cases, hematologists compared with generalists in children' s hospitals trended toward low transfusion rates and low intubation rates, whereas the opposite effect was seen in general hospitals. This surprising trend may imply that patients admitted to children's hospitals are well-known to the pediatric hematologists, who may have relative comfort observing rather than transfusing or intubating due to increased familiarity with a patient's pattern of disease progression or other clinical factors not captured by billing data. We also do not know how pediatric hematologists in these children' s hospitals compare with those of all free-standing children's hospitals.
Despite the limitations described earlier, this study was able to compare the quality of care for A/YA with SCD across children's hospitals and general hospitals across the country. Our findings support the need to better understand quality of care variations across different hospital settings, and the impact of ambulatory care on hospital outcomes, particularly for A/YA with SCD who are transitioning to adult services. 
